Table 6

Repeated measures analysis between effects for patient and treatment groups and cost categories shown in table 5

In-hospital costsOutpatient costsDrug treatmentPrimary health and private practice specialistsSocial securityLabour market income
p Valuep Valuep Valuep Valuep Valuep Value
 Control vs no treatment<0.0001<0.0001<0.0001<0.00010.00010.756
 Control vs CPAP<0.0001<0.0001<0.0001<0.00010.16480.3468
 Control vs return CPAP0.42470.001<0.0001<0.00010.26190.5184
 No treatment vs CPAP0.00430.1143<0.00010.16050.26840.3594
 No treatment vs return CPAP0.69450.2480.0040.07160.37310.531
 CPAP vs return CPAP0.03380.91190.07870.61610.98810.9217
Sleep apnoea
 Control vs no treatment<0.0001<0.0001<0.0001<0.0001<0.0001<0.0001
 Control vs CPAP<0.0001<0.0001<0.0001<0.0001<0.00010.0002
 Control vs return CPAP0.1128<0.0001<0.0001<0.0001<0.00010.3736
 No treatment vs CPAP<0.0001<0.0001<0.0001<0.00010.00390.5408
 No treatment vs return CPAP0.00190.24140.00360.85320.19760.128
 CPAP vs return CPAP<0.00010.02180.0131<0.00010.45070.1129
  • Significance levels refer to the relative changes 2 years before and after diagnosis for the tested groups and cost categories.

  • CPAP, continuous positive airway pressure.